3-Methylcrotonyl-CoA Carboxylase Deficiency: Phenotypic Variability in a Family

Abstract

A family with 3-methylcrotonyl-CoA carboxylase deficiency with different clinical features is described. A 15-month-old boy, who was the index patient, was admitted to the hospital with atonic seizure. His brother had delayed language development and their uncle had been followed with diagnosis of epilepsy for the last 5 years. Urinary organic acid analysis displayed elevated 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, analysis of acylcarnitines showed elevated 3-hydroxyisovalerylcarnitine and decreased free carnitine levels in both the patients and their uncle. Methylcrotonyl-CoA carboxylase activity in cultured fibroblasts displayed a low residual activity of 2.2% of the median control value while propionyl-CoA carboxylase activity was normal in the index patient. Mutation analysis revealed a large homozygous deletion of 2264 bp (c.873+4524_6787de12264) in the MCCA gene, which has not been described to date. Adult-onset afebrile seizures have not been reported in the literature. Our cases are an example of this wide phenotypic variability within a single family.

Keywords

3-methylcrotonyl-CoA carboxylase (MCC) deficiency seizure mutation

Get full access to this article

View all access options for this article.

References

Baumgartner MR , Almashanu S. , Suormala T. , et al. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. J Clin Invest. 2001 ;107:495-504.

Naylor EW , Chace DH Automated tandem mass spectrometry for newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol. 1999;14:4-8.

Wilcken B. , Wiley V. , Hammond J. , Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry . N Eng J Med. 2000;348:2304-2312.

Dantas MF , Suormala T. , Randolph A. , et al. 3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening. Hum Mutat. 2005;26:164.

Sweetman L. , Williams JC Branched chain organic acidurias. In: Scriver CR , Beaudet AL , Sly WS , Valle D , eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:2125-2163.

Bannwart C. , Wermuth B. , Baumgartner R. , et al. Isolated biotin-resistant deficiency of 3-methylcrotonyl-CoA carboxylase presenting as a clinically severe form in a newborn with fatal outcome. J Inherit Metab Dis. 1992;15:863-868.

Baykal T. , Gokcay GH , Ince Z. , et al. Consanguineous 3-methylcrotonyl-CoA carboxylase deficiency: early-onset necrotizing encephalopathy with lethal outcome. J Inherit Metab Dis. 2005;28:229-233.

Friebel D. , von der Hagen M. , Baumgartner ER , et al. The first case of 3 methylcrotonyl-CoA carboxylase (MCC) deficiency responsive to biotin. Neuropediatrics. 2006 ;37:72-78.

Roeschinger W. , Millington DS , Gage DA , et al. 3-Hydroxyisovalerylcarnitine in patients with deficiency of 3-methylcrotonyl CoA carboxylase. Clin Chim Acta. 1995;240: 35-51.

10.

Oude Luttikhuis HG , Touati G. , Rabier D. , Williams M. , Jakobs C. , Saudubray JM Severe hypoglycaemia in isolated 3-methylcrotonyl-CoA carboxylase deficiency; a rare, severe clinical presentation. J Inherit Metab Dis. 2005;28: 1136-1138.

11.

Stadler SC , Polantz R. , Maier EM , et al. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment . Hum Mutat. 2006;27:748-759.

12.

Jurecki E. , Packman S. Nutritional therapy for beta-methylcrotonylglycinuria. Metab Curr. 1992;5:9-12.

13.

Matern D. , Rinaldo P. Medium-chain acyl-coenzyme A dehydrogenase deficiency database. GeneReviews: Genetic Disease Online Reviews at GeneTests-GeneClinics (University of Washington, Seattle), 2003.